ozempic lawsuit Updates
New Lawsuit Alleges Wegovy Caused Severe Gastrointestinal Injuries
A plaintiff from Cabazon, California, has filed a lawsuit alleging she suffered severe and potentially permanent gastrointestinal injuries from using Wegovy. The complaint states that after starting the drug in May 2023, she developed ileus and gastroparesis, conditions that caused significant pain, vomiting, and required medical intervention. The lawsuit accuses Novo Nordisk of failing to adequately warn consumers and physicians about the risks of serious gastrointestinal events requiring emergency care. It further contends the company aggressively marketed Wegovy as a "miracle" drug while downplaying its risks and misleading the public about its long-term safety profile.
Strategic Shift in Ozempic Litigation Towards Vision Loss Claims
Plaintiffs' efforts to link Ozempic to gastroparesis have faced significant causation challenges. Consequently, litigation focus has shifted decisively to claims of non-arteritic anterior ischemic optic neuropathy (NAION), a form of sudden, often permanent vision loss. This new theory presents a stronger narrative, bolstered by a recent European Medicines Agency mandate for warning labels about this specific risk. NAION provides a more direct causation argument, as it is a severe, distinct event not typically linked to diabetes, thereby clarifying damages for juries. Our legal strategy is now prioritizing these vision loss cases.
New Study Links Ozempic to Increased Risk of Permanent Vision Loss
A new study published in the Journal of the American Medical Association (JAMA) has found that patients taking Ozempic for type 2 diabetes were twice as likely to develop a permanent vision loss condition known as nonarteritic anterior ischemic optic neuropathy (NAION). This condition typically causes irreversible blurred or lost vision. Although these specific claims are not currently part of the ongoing multidistrict litigation (MDL), the defendants, including Novo Nordisk, have unusually requested to consolidate NAION lawsuits into a separate MDL. This move may suggest the manufacturer recognizes the significant and permanent risks associated with the drug.
Eli Lilly Moves to Centralize GLP-1 Vision Loss Lawsuits
Eli Lilly has filed a motion to centralize all federal lawsuits alleging its GLP-1 drugs (Mounjaro, Trulicity) and Novo Nordisk's (Ozempic, Wegovy) caused vision loss (NAION). The motion proposes consolidating these claims into a new MDL or the existing GI injury MDL (No. 3094). Lilly specifically requests assignment to Judge Karen Marston in the Eastern District of Pennsylvania, citing her efficiency and familiarity with the underlying science and regulatory history. This proactive move, unusual for a defendant, signals a strategic preference for her oversight. The NAION docket continues to grow regardless of the motion's outcome.
About the Ozempic Lawsuit
The Ozempic lawsuit has recently gained significant attention as concerns have been raised about Ozempic long term side effects, including gastroparesis, thyroid C-cell tumors, and other serious illnesses.
The core issue of the Ozempic class action lawsuit is the potential serious health risks associated with the use of Ozempic, a medication commonly prescribed to manage type 2 diabetes by controlling blood sugar levels. These issues have led to numerous reports and studies focusing on the potential dangers of the active ingredient in Ozempic, semaglutide.
People afflicted with Ozempic's long-term side effects include individuals who have been prescribed the medication for diabetes management and subsequently experienced serious health issues. Individuals who used Ozempic for weight loss were unaware of the potential risks associated with the medication.
Victims who used Ozempic for weight loss are facing significant health challenges, permanent disabilities, and, in some cases, life-threatening conditions. Many people are unaware of the risks and continue using the medication, only to experience severe health issues. Legal avenues are now available for those affected, allowing them to submit an application and seek potential compensation for the harm caused by Ozempic.
If you or a loved one have suffered serious health issues after using Ozempic, it is crucial to understand your rights and the potential for participating in the Ozempic lawsuit to seek justice and compensation.
Who Qualifies for the Ozempic Lawsuit?
There are specific criteria you must meet to potentially qualify for the Ozempic lawsuit. These requirements include.
Medication Use:
You must have been prescribed and used Ozempic between 2018 and to present.
Health Conditions: You must have been diagnosed with one of the following Ozempic side effects:
- Persistent cyclical vomiting for +4 weeks (diagnosis must be while taking the product OR within 60 days of stopping and must have experienced vomiting 1 month or more)
- Gastric Injury (diagnosis must be while taking product OR within 60 days of stopping)
- A gastric injury is any injury related to the gastrointestinal tract
- Ileus
- Gastroparesis/ stomach paralysis
- Pulmonary Aspiration (associated with anesthesia/surgery)
- Deep Vein Thrombosis (DVT)
- Esophageal Injury
If you do not have a valid cancer diagnosis from your doctor but have experienced Ozempic side effects, you may still be included in the Ozempic lawsuit.
If you meet these requirements, you may be entitled to compensation and should seek legal advice to determine your eligibility.
Which Companies Are Involved in the Ozempic Lawsuit?
Several manufacturers and their respective products are commonly implicated in the Ozempic lawsuit, however, the primary company involved is Novo Nordisk. Novo Nordisk is facing numerous lawsuits alleging that the science behind Ozempic was wrong and that it has led to serious health conditions, including gastroparesis, ileus, and other significant health issues.
These Ozempic lawsuits claim that Novo Nordisk failed to adequately warn users about the potential risks associated with the drug's active ingredient, semaglutide. As more evidence emerges linking to Ozempic's long-term side effects, the number of cases against the company is expected to increase. If you or a loved one have experienced adverse health effects after using Ozempic, you may qualify to join the ongoing litigation.
How Much Compensation Should You Expect In Your Ozempic Lawsuit?
Determining a typical settlement amount in the Ozempic lawsuit is complex due to the unique nature of each case. Factors such as the severity of the illness, the strength of the evidence, jury decisions, and the skill of the lawyers involved all influence the settlement amount.
As of now, the Ozempic lawsuits are in the early stages, and no global settlements or jury trials have been reported. However, based on other pharmaceutical litigation and the current scope of the Ozempic cases, potential settlement amounts can be anticipated based on the type and extent of harm suffered by plaintiffs.
Add Comment